FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8941001000001100: Not available (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40299001000001111 Not available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40299101000001112 Not available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Not available Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seven Seas Cranberry Forte 200mg capsules (Seven Seas Ltd) 50 capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Pabal 100micrograms/1ml solution for injection ampoules (Ferring Pharmaceuticals Ltd) 5 ampoule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 2g powder and solvent for solution for injection vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 1g solution for infusion vials VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Gemcitabine 200mg solution for infusion vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 2g solution for infusion vials VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Indocyanine green 25mg powder and solvent for solution for injection vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 1g solution for infusion vials 1 vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Gemcitabine 2g solution for infusion vials 1 vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 2g powder and solvent for solution for injection vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 1g/26.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Solu-Medrone 2g powder and solvent for solution for injection vials (Pfizer Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 200mg solution for infusion vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Indocyanine green 25mg powder and solvent for solution for injection vials 6 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 200mg/5.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 1g concentrate for solution for infusion vials (Hospira UK Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
IC-Green 25mg powder and solvent for solution for injection vials (Imported (United States)) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 200mg concentrate for solution for infusion vials (Hospira UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 2g concentrate for solution for infusion vials (Hospira UK Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Gemcitabine 1g concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Gemcitabine 200mg concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 1g/26.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Gemcitabine 200mg/5.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Solu-Medrone 2g powder and solvent for solution for injection vials (Pfizer Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Gemcitabine 2g concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
IC-Green 25mg powder and solvent for solution for injection vials (Imported (United States)) 6 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Chlorocresol powder VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Albiglutide 30mg powder and solvent for solution for injection pre-filled disposable devices VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Albiglutide 50mg powder and solvent for solution for injection pre-filled disposable devices VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid (J M Loveridge Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Chlorocresol powder 25 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid 25 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid 500 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid 100 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Chlorocresol powder (J M Loveridge Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid (J M Loveridge Plc) 500 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid (J M Loveridge Plc) 25 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Anise oil liquid (J M Loveridge Plc) 100 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Chlorocresol powder (J M Loveridge Plc) 25 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Eperzan 50mg powder and solvent for solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Eperzan 30mg powder and solvent for solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Albiglutide 30mg powder and solvent for solution for injection pre-filled disposable devices 4 pre-filled disposable injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Albiglutide 50mg powder and solvent for solution for injection pre-filled disposable devices 4 pre-filled disposable injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Eperzan 50mg powder and solvent for solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 4 pre-filled disposable injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Eperzan 30mg powder and solvent for solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 4 pre-filled disposable injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 40 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely pindolol 15 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely diloxanide furoate 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets 56 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (Amdipharm) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Bambec 20mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Cyanocobalamin 35micrograms/5ml oral solution (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets 56 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Trasicor 20mg tablets (Amdipharm) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Visken 15mg tablets (Amdipharm) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Diloxanide 500mg tablets (Unichem Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (PI) (Waymade Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Bambuterol 20mg tablets 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (Lexon (UK) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (Sovereign Medical Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Amiloride 2.5mg / Cyclopenthiazide 250microgram tablets 28 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Pindolol 15mg tablets 28 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Cyanocobalamin 35micrograms/5ml oral solution 200 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Diloxanide 500mg tablets (Sovereign Medical) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Cytacon 35micrograms/5ml liquid (Goldshield Healthcare Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Bambuterol 20mg tablets 28 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Diloxanide 500mg tablets 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Trasicor 40mg tablets (Amdipharm) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Pindolol 10mg / Clopamide 5mg tablets 28 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Bambec 20mg tablets (AstraZeneca) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Diloxanide 500mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (Sovereign Medical Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Cyanocobalamin 35micrograms/5ml syrup (AMCo) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Bambec 20mg tablets (Sigma Pharmaceuticals Plc) 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Diloxanide 500mg tablets (A A H Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (Doncaster Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (Sovereign Medical Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Cyanocobalamin 35micrograms/5ml syrup (AMCo) 200 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Cytacon 35micrograms/5ml liquid (Goldshield Healthcare Ltd) 200 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Trasicor 40mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Trasicor 20mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Viskaldix tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Diloxanide 500mg tablets (Unichem Plc) 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier

Start Previous Page 279 of 304 Next End

This concept is not in any reference sets

Back to Start